IL1RL1 and neoplasm: IL-33 signals via its unique receptor ST2, which is expressed on several cell types.3 To identify the cells potentially reacting to IL-33 in the tumor microenvironment, we next measured ST2 expression on tumor-infiltrating immune cells.